418 related articles for article (PubMed ID: 10073058)
41. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.
Liso V; Specchia G; Pogliani EM; Palumbo G; Mininni D; Rossi V; Teruzzi E; Mestice A; Coppi MR; Biondi A
Cancer; 1998 Oct; 83(8):1522-8. PubMed ID: 9781945
[TBL] [Abstract][Full Text] [Related]
42. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
43. All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure.
Ahmed Z; Shaikh MA; Raval A; Mehta JB; Byrd RP; Roy TM
South Med J; 2007 Sep; 100(9):899-902. PubMed ID: 17902291
[TBL] [Abstract][Full Text] [Related]
44. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
45. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
Zhang T; Westervelt P; Hess JL
Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
[TBL] [Abstract][Full Text] [Related]
46. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
47. A complex, four-way variant t(15;17) in acute promyelocytic leukemia.
Yoo SJ; Seo EJ; Lee JH; Seo YH; Park PW; Ahn JY
Cancer Genet Cytogenet; 2006 Jun; 167(2):168-71. PubMed ID: 16737919
[TBL] [Abstract][Full Text] [Related]
48. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
[TBL] [Abstract][Full Text] [Related]
49. Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
Laczika K; Mitterbauer G; Korninger L; Knöbl P; Schwarzinger I; Kapiotis S; Haas OA; Kyrle PA; Pont J; Oehler L
Leukemia; 1994 Jan; 8(1):1-5. PubMed ID: 8289472
[TBL] [Abstract][Full Text] [Related]
50. Acute promyelocytic leukemia and HIV-1 infection: case report and review of the literature.
Kudva GC; Maliekel K; Richart JM; Batanian JR; Grosso LE; Sokol-Anderson M; Petruska PJ
Am J Hematol; 2004 Nov; 77(3):287-90. PubMed ID: 15495246
[TBL] [Abstract][Full Text] [Related]
51. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
52. Masked t(15;17) APL with the insertion of PML-RARalpha fusion gene in 4q21.
Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Itoyama T; Gotoh M; Taniwaki M; Tubouchi H
Leuk Res; 2009 Nov; 33(11):1552-5. PubMed ID: 19477514
[TBL] [Abstract][Full Text] [Related]
53. Treatment of acute promyelocytic leukaemia.
Fenaux P; Chomienne C; Degos L
Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
[TBL] [Abstract][Full Text] [Related]
54. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
[TBL] [Abstract][Full Text] [Related]
55. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.
Teng HW; Bai LY; Chao TC; Wang WS; Chen PM
Jpn J Clin Oncol; 2005 Feb; 35(2):94-6. PubMed ID: 15709095
[TBL] [Abstract][Full Text] [Related]
56. [Therapy-related acute promyelocytic leukemia with a t(9;22)(q34;q11) and t(15;17)(q22;q11 to approximately 12) subclone].
Mochiduki Y; Muramoto S
Rinsho Ketsueki; 2005 Nov; 46(11):1218-22. PubMed ID: 16440807
[TBL] [Abstract][Full Text] [Related]
57. [Progress in biology and the treatment of acute promyelocytic leukemia].
Robak T
Acta Haematol Pol; 1993; 24(1):13-21. PubMed ID: 8488732
[TBL] [Abstract][Full Text] [Related]
58. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
[TBL] [Abstract][Full Text] [Related]
59. All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
Masetti R; Vendemini F; Zama D; Biagi C; Gasperini P; Pession A
Expert Rev Anticancer Ther; 2012 Sep; 12(9):1191-204. PubMed ID: 23098119
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients.
Adès L; Chevret S; Raffoux E; Guerci-Bresler A; Pigneux A; Vey N; Lamy T; Huguet F; Vekhoff A; Lambert JF; Lioure B; de Botton S; Deconinck E; Ferrant A; Thomas X; Quesnel B; Cassinat B; Chomienne C; Dombret H; Degos L; Fenaux P;
Am J Hematol; 2013 Jul; 88(7):556-9. PubMed ID: 23564205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
